#
##
##
##
|||||||Page No|
|---|---|---|---|---|---|---|
|Corporate Trustee's
Report for the|financial||year|||2|
|Foreword to the Financial Statements||||||14|
|Statement ofTrustee's
Responsibilities||||||15|
|Independent
Auditors'
Report to the Trustees of||||||16|
|Southern
Health
NHS Foundation|Trust General|||Fund|||
|Statement of Financial Activities||||||20|
|Balance Sheet||||||21|
|Statement
ofCash Flows||||||22|
|Reconciliation
ofnet income I(expenditure)|||to net cash||flow|22|
|from operating
activities|||||||
|Analysis ofcash and cash equivalents||||||22|
|Notes to the Financial Statements|||||||
|1.
Accounting
Policies||||||23|
|2.
Total donations
and legacies||||||25|
|3.
Grants payable||||||26|
|4.
Management
and administration||costs||||26|
|5.
Transfer offunds to other NHS charities||||||26|
|6.
Investments||||||26|
|7.
Debtors||||||27|
|8.
Creditors: amounts
falling due within one year||||||27|
|9.
The funds ofthe Charity||||||28|
|10.
Contingencies||||||29|
|11.
Commitments||||||29|
|12.
Liabilities and provisions||||||29|
|13.
Corporate Trustee and connected||persons||transactions||29|
|14.
Post Balance Sheet events||||||29|
|15.
Related party transactions||||||29|
|16.
Consolidation
ofthe Charity's|financial||statements||with its|29|
|parent's
financial statements|||||||
##
##
##
##
##
##
##
|||||2021/22|2020/21|
|---|---|---|---|---|---|
|||||6'000|6'000|
|Investments|with the investment|mana|er|565|657|
|Cash held|in Trust's charitable|fund bank accounts||60|67|
|Debtors||||72|25|
|Creditors||||28|16|
|Total||||669|733|
##
##
##
##
|harities Act2011.The dire
April 2021 within the Trust|ctors who acted o
were:|n behalf ofthe Corporate Trustee from|
|---|---|---|
|Trustee|Period of|Office|
|Michael Bernard|Appointed|14 May 2019|
|Lynne
Hunt|Appointed|3July 2017|
|David Kelham|Appointed|14July 2017|
|David Monk|Appointed|14July 2017to 13July 2021|
|Jennifer Bremner|Appointed|14July 2017|
|Dr David Hicks|Appointed|1 January 2018|
|Robert Goldsmith|Appointed|1 October 2018to 5 October 2021|
|Dr Subashini
M|Appointed|19January 2021|
|Ade Williams|Appointed|12 February 2021|
|Dr Kevin Cleary|Appointed|28 Apdil 2022|
|Paula Anderson|Appointed|1 June 2016|
|Paula
Hull|Appointed|1 July 2017|
|Ron Shields|Appointed|8June 2020|
|Paul Draycott|Appointed|1 January 2018|
|Dr Karl Marlowe|Appointed|9 April 2018to 30April 2021|
|Kate FitzGerald|Appointed|14 May 2019|
|Grant Macdonald|Appointed|4 November 2019to 19March 2022|
|Heather
Mitchell|Appointed|5August 2019|
|Dr Stephen Tomkins|Appointed|4 May 2021|
|Eugene Jones|Appointed|1 April 2022|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Reconciliation ofnet income
/ (expenditure)|Reconciliation ofnet income
/ (expenditure)||to net cash|to net cash|flow from||||
|---|---|---|---|---|---|---|---|---|
|operating
activities|||||||2021/22|2020/21|
|||||||Note|KOOO|KOOO|
|Netincome
(expenditure)
for the reporting|||period (asper the||||||
|income Statement)
Adjustments
for:|||||||(64)|208|
|Realised (Gains)/losses
on investments|||||||(10)||
|Dividends,
interest and rents from investments|||||||(22)|(24)|
|Loss/(profit)
on the unrealised
loss/(gain)|||||||2|(101)|
|(Increase)
in debtors|||||||(47)|(25)|
|Increase/(Decrease)
in creditors
Net cash provided by (used in) operating||activities|||||12
(129)|(26)
32|
||||||||2021/22|2020/21|
|||||||Note|KOOO|KOOO|
|Cash flows from operating
activities:|||||||||
|Net cash provided by (used in) operating|activities|||||See|(129)|32|
|||||||above|||
|Cash flows from investing
activities|||||||||
|Dividends,
interest and rents from investments|||||||22|24|
|Proceeds from sale of investments|||||||100||
|Net cash pmvided
by (used in)investing|activities||||||122|24|
|Change
in cash and cash equivalents|in the||reporting|period|||(7)|56|
|Cash and cash equivalents
at the beginning||ofthe reporting|||period||67|11|
|Cash and cash equivalents
at the end|ofthe||reporting|period|||60|67|
|Analysis ofcash and cash equivalents|||
|---|---|---|
||2021/22|2020/21|
||KOOO|KOOO|
|Total cash and cash equivalents|60|67|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Restricted|2021/22 Total 2020/21 Total|2021/22 Total 2020/21 Total|
|---|---|---|---|---|---|---|
||||Funds f000s|Funds f000s|Funds f000s Funds f000s||
|Auditor's
remuneration|||||||
|Investment
ManageFS||fee|||||
|Insurance/other|fees||||||
|Administration|fee||30|47|77|69|
|Total|||36|54|90|80|
##
##
##
##
||applied to the funds|a|s a|nd when g|ains an|d l|osses|arise.|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||No|of Units|31/3/2022|Percentage of|
||Investment
Vehicle||||||||||Fair Value|Total|
||||||||||||0000|Investment|
||Sarasins
Income &Reserves|||Fund Class|A Inc|||||377,647|470|83'Y|
||Sarasin Income and Reserves|||Fund Class|A Inc|||||87,364|95|17'%|
||TOTAL||||||||||565|100|
||Fair value at 31st|March||2022|||||||||
||||||||Held|in UK|Held|outside UK|31/3/2022|31/3/2021|
|||||||||feces||fccc|To/a/|To/al|
||||||||||||feces|fooos|
||Sarasin Fund Class A|||||||238||327|565|657|
||Analysis ofgross|income from investmente|||||||||||
||||||||Held|in UK|Held|oulside UK|31/3/2022|31/3/2021|
|||||||||fcoos||3000|To/a/|Total|
||||||||||||2Ossa|2ceca|
||Sarasin
Fund Class A|||||||||13|22|24|
|7.|Debtors||||||||||||
||||||||||||31/3/2022 feces|31/3/2021 feces|
||Legacy not yet received||||||||||64|25|
||Prepayment||||||||||1||
||Grants due from League|||of Friends|||||||7||
||Debtors||||||||||72|25|
|8.|Creditors: amounts||falling due within one||||year||||||
||||||||||||31/3/3022 feces|3u3/2021 fsoes|
||Audit fee due to Knight Goodhead||||Ltd||||||5|5|
||Owed to Southern|Health||NHS Foundation||Trust (Exchequer)|||||23|11|
||Total creditors fallin||due within||one|ear|||||28|16|
##
##
##
##
##
##
##
##